CELLDEX Trademark

Trademark Overview

On Thursday, April 13, 2023, a trademark application was filed for CELLDEX with the United States Patent and Trademark Office. The USPTO has given the CELLDEX trademark a serial number of 97887331. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Thursday, June 12, 2025. This trademark is owned by CELLDEX. The CELLDEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer
celldex

General Information

Serial Number97887331
Word MarkCELLDEX
Filing DateThursday, April 13, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateThursday, June 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 13, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of inflammation and inflammatory diseases; therapeutic antibodies for human use for the treatment of inflammation and inflammatory diseases; Pharmaceutical preparations for the treatment of cancer; therapeutic antibodies for human use for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCELLDEX
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827
Party NameCELLDEX
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827

Trademark Events

Event DateEvent Description
Monday, April 17, 2023NEW APPLICATION ENTERED
Tuesday, April 18, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 18, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 18, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, May 5, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, May 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 26, 2023ASSIGNED TO LIE
Tuesday, September 26, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 26, 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, January 9, 2024ASSIGNED TO EXAMINER
Tuesday, January 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 13, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 24, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2024PUBLISHED FOR OPPOSITION
Tuesday, October 8, 2024SOU EXTENSION 1 FILED
Monday, November 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 9, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2025SOU EXTENSION 2 FILED
Tuesday, May 6, 2025NOTICE OF REVIVAL - E-MAILED
Tuesday, May 6, 2025TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 6, 2025SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, November 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Tuesday, May 6, 2025PETITION TO REVIVE-GRANTED
Monday, May 12, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 12, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, June 9, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 12, 2025SOU EXTENSION 1 GRANTED
Thursday, June 12, 2025SOU EXTENSION 2 GRANTED
Friday, June 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 10, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, May 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

celldex treatment antibodies human therapeutic cancer inflammatory preparations inflammation pharmaceutical diseases